Zobrazeno 11 - 20
of 93
pro vyhledávání: '"Jian Gu"'
Publikováno v:
Future Oncology. 15:1667-1678
Aim: To identify whether PD-L1 expression and EGFR status are associated with response to treatment benefit in advanced non-small-cell lung cancer (NSCLC) patients receiving PD-1/PD-L1 inhibitors. Methods: The relevant studies were retrieved and syst
Publikováno v:
APMIS. 127:468-474
Acute liver injury can result from a number of different diseases. Inflammatory cytokines are known to be involved in the development of this condition; however, their precise roles and effects on liver function remain unclear. The goal of this study
Autor:
Yongxiang Xia, Ling Lu, Xuehao Wang, Ji Gao, Jian Gu, Zheng Ju, Shaopeng Zhang, Xiongxiong Pan, Xiaojie Gan
Publikováno v:
Cell Death and Disease, Vol 10, Iss 5, Pp 1-13 (2019)
Cell Death & Disease
Cell Death & Disease
In vitro induced human regulatory T cells (iTregs) have in vivo therapeutic utility. MicroRNAs (miRNAs) are a family of approximately 22-nucleotide non-coding RNAs that are processed from longer precursors by the RNases Drosha and Dicer. miRNAs regul
Publikováno v:
Critical Reviews in Oncology/Hematology. 134:31-38
We performed an meta-analysis to fully investigate the diarrhea of EGFR-TKIs in cancer patients. The relevant studies of the randomized controlled trials (RCTs) in cancer patients treated with EGFR-TKIs were retrieved and the systematic evaluation wa
Publikováno v:
Journal of Cancer
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths due to tumor invasiveness, frequent intrahepatic dissemination and extrahepatic metastasis. However, the genes and signaling pathways that are involved remain incomp
Autor:
Liping Liu, Hong-Hu Zhu, Jian Gu, Jingru Zhang, Xiaotong Yu, Libo Zhao, Chongya Dong, Zhenwei Xie
Publikováno v:
Critical Reviews in Oncology/Hematology. 133:120-128
Background Peripheral-blood (PB) and bone marrow (BM) are both widely used in hematopoietic stem cell transplantation (HSCT). However, it is unclear whether PB or BM produces a more satisfactory outcome in haploidentical HSCT, particularly for patien
Autor:
Ming Hou, Ying Feng, Heng Mei, Tienan Zhu, Zeping Zhou, Ting Niu, Yu Hu, Lei Su, Feng Xue, Lin-Hua Yang, Ruibin Huang, Yan Li, Lili Luo, Jun Peng, Yuhong Zhou, Qiulan Ding, Ying-Ying Wu, Jianming Feng, Jian Gu, Xiao-Hui Zhang, Jun Deng, Yue Han, Xiaomin Wang
Publikováno v:
Thrombosis Research. 173:131-140
Disseminated intravascular coagulation (DIC) is a severe complication of critical conditions. There are several scoring systems used for the diagnosis of DIC, including the International Society on Thrombosis and Hemostasis (ISTH) Overt-DIC criteria,
Publikováno v:
Immunotherapy. 10:1293-1302
Aim: We conducted a meta-analysis to systematically review the efficacy and safety of programmed cell death 1 (PD-1) inhibitors for advanced melanoma. Study design: The relevant studies of the randomized controlled trials in melanoma patients treated
Autor:
Zhen Luo, Wei Pan, Menglin Liu, Jian Gu, Dan Li, Menglong Wang, Bo Shen, Yao Xu, Pingan Zhang, Zhen Wang, Jun Wan, Mengmeng Zhao, Mingxiao Liu, Jianfang Liu, Hua He, Di Ye, Jishou Zhang, Jing Ye
Publikováno v:
Clinica Chimica Acta
Clinica Chimica Acta; International Journal of Clinical Chemistry
Clinica Chimica Acta; International Journal of Clinical Chemistry
Cases of coronavirus disease 2019 (COVID-19) have been breaking out around the world recently. However, the dynamic changes in the clinical symptoms and prognosis of COVID-19 patients remain unknown. According to the onset time of initial clinical sy
Autor:
Wan-Jian Gu, Jingyu Liu, Xiaoyu Ding, Xiaoyao Hao, Lan Luo, Yujie Zhong, Mingjiu Chen, Shukai Xia, Chunni Zhang
Publikováno v:
EBioMedicine, Vol 60, Iss, Pp 102996-(2020)
EBioMedicine
EBioMedicine
Background: Pertuzumab is currently used in combination with trastuzumab as the first-line treatment for HER2-positive metastatic breast cancer. However, pertuzumab was originally developed independently from trastuzumab and was later incidentally fo